Skip to content

A Phase 1, drug-drug interaction trial of IMU-838 with oral contraceptives in women

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-525208-90-00
Enrollment
26
Registered
2026-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis

Interventions

None listed

Sponsors

Immunic AG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Mar 17, 2026